Jam

Kyverna Therapeutics will present interim Phase 2 KYSA-6 trial results for KYV-101 in myasthenia gravis at the AANEM meeting in October 2025. Data from six patients with up to 9 months follow-up will be shared. KYV-101, a CD19 CAR T-cell therapy, aims for durable remission after a single dose. The study has been upgraded to a registrational Phase 2/3 trial, with Phase 3 initiation planned by year-end 2025. The presentation by Dr. Srikanth Muppidi will be on October 29th.

Docusign’s Intelligent Agreement Management (IAM) platform achieved FedRAMP Moderate authorization, enabling secure and compliant agreement solutions for U.S. federal agencies. This empowers agencies to modernize agreement processes, increase efficiency, improve service delivery, and unlock insights with AI. IAM facilitates digital transformation, replacing outdated paper-based workflows with AI-enhanced processes, improving security, and reducing costs. Agencies can now confidently deploy Docusign’s IAM to manage agreements faster and more securely, furthering government initiatives for digital services and cloud-based solutions.

Harbor Capital Advisors celebrates the third anniversary of the Harbor International Compounders ETF (OSEA). Partnering with C WorldWide, OSEA offers a concentrated portfolio of approximately 30 high-performing international “compounders” selected based on fundamental research and long-term secular themes. The ETF prioritizes company fundamentals over geography, targeting resilient businesses with strong growth and cash flow. As of June 30, 2025, OSEA at NAV has a 3-year average annual return of 14.11% and 15.07% since inception (9/7/22). Performance data is past performance and not a guarantee of future results.

B2Gold (BTG) updated operations across its mines, reaffirming its 2025 gold production guidance of 970,000-1,075,000 ounces. The Goose Mine achieved first gold pour, but crushing plant issues led to reduced 2025 guidance. Otjikoto and Masbate mines are outperforming, increasing their production outlooks. Fekola underground operations commenced, with positive results. The Antelope underground project at Otjikoto was approved with reduced capital costs. Fekola Regional’s exploitation permit is expected soon, projecting 180,000 ounces annually from 2026-2030.

ACG Metals (LSE: ACG) reported strong H1 2025 results, driven by high precious metal prices and operational efficiencies at Gediktepe mine. Key achievements include settling a $200M bond for the Gediktepe sulphide expansion, strengthening the balance sheet with repaid debt, and strategic appointments. H1 EBITDA reached $36M and cash flow from operations $31M. Gediktepe is on track for copper/zinc production by H1 2026. The company also commenced trading on the OTCQX Best Market in the U.S. Future growth relies on increasing copper demand and successful project execution.

Evercore ISI has appointed Alexander Virgo as Senior Managing Director in London to lead coverage of global multi-industry companies. Virgo brings nearly 25 years of industrial sector experience, including top-ranked equity research roles at Bank of America and other firms. This strategic hire aims to strengthen Evercore ISI’s sector expertise and provide clients with comprehensive insights amidst significant changes in global industrial supply chains. Virgo’s background includes experience at Nomura, Berenberg, Credit Suisse, Och Ziff and UBS spanning from equity research, cyclicals coverage and investment banking.

Kelyniam Global’s CFO, Terrance Kurtenbach, will present at the Life Sciences Virtual Investor Forum on September 18, 2025, at 10:00 AM EDT. The forum allows investors to learn about Kelyniam’s growth strategy and innovative custom cranial implants leveraging CAD/CAM technology and advanced medical-grade polymers. Management will be available for one-on-one meetings. Kelyniam focuses on personalized solutions and is expanding into regenerative medicine with licensed products.

Alamos Gold will sell its Turkish assets for $470 million to Tümad, payable over two years with bank guarantees. This strategic divestiture allows Alamos to focus on North American growth projects like Island Gold and Lynn Lake, reduce debt, and resolve pending arbitration. The transaction is expected to close in Q4 2025, pending regulatory approval. Proceeds will fund expansion projects and strengthen the balance sheet. Although exiting the Turkish market, the deal offers a secure financial return and a de-risked portfolio.

American Heritage International (AHII) has signed an agreement to acquire Freightmaster Semi-Trailers, an Australian heavy transport equipment manufacturer since the 1990s. This supports AHII’s Roadships initiative and development of critical rolling stock, including ship unloaders and specialized trailers. AHII plans to leverage Freightmaster’s brand and expertise by establishing US-based production facilities for both civilian and defense logistics markets. The acquisition aims to optimize on-road transportation and accelerate the realization of AHII’s intermodal transport vision.

Sidus Space (SIDU) announced a public offering of 9.8 million Class A common shares at $1.00 per share, expecting gross proceeds of $9.8 million. The offering is set to close on September 16, 2025, with ThinkEquity as the sole placement agent. Net proceeds will go towards working capital and general corporate expenses. This capital raise aims to support Sidus Space’s operations and strategic investments amid rising competition in the space technology sector. The offering is based on a shelf registration statement filed with the SEC.